Rizatriptan

CHEMBL905 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

269.3 g/mol

LogP

1.7

Phase

4

A triptan medication used to treat acute migraine attacks, with or without aura, by constricting dilated blood vessels and blocking pain signals in the brain. It works within 30 minutes for most patients and is available in both regular tablets and orally disintegrating formulations.

분자량

269.3400 g/mol

LogP

1.70

TPSA

49.70 Å²

리핀스키 5의 법칙

통과

치료 영역

Cardiovascular Disease Parkinson's Disease Epilepsy Migraine Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12

InChI

InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3

Molecular Formula

C15H19N5

HBD / HBA

1 / 3

회전 가능 결합

5

무거운 원자

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A triptan medication used to treat acute migraine attacks, with or without aura, by constricting dilated blood vessels and blocking pain signals in the brain. It works within 30 minutes for most patients and is available in both regular tablets and orally disintegrating formulations.

Yes, Rizatriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL905. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5078. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Rizatriptan PillFYI에서

구조

핵심 데이터

분자식: C15H19N5
동의어: 5

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.